Author:
Ortiz-Urda Susana,Ho Wilson,Lee Albert
Publisher
Springer International Publishing
Reference72 articles.
1. Colebatch AJ, Scolyer RA. Trajectories of premalignancy during the journey from melanocyte to melanoma. Pathology (Phila). 2018;50(1):16–23.
2. Melamed RD, Aydin IT, Rajan GS, Phelps R, Silvers DN, Emmett KJ, et al. Genomic characterization of dysplastic nevi unveils implications for diagnosis of melanoma. J Invest Dermatol. 2017;137(4):905–9.
3. Erlich TH, Fisher DE. Pathways in melanoma development. G Ital Dermatol E Venereol. 2018;153(1):68–76.
4. Tsao H, Chin L, Garraway LA, Fisher DE. Melanoma: from mutations to medicine. Genes Dev. 2012;26(11):1131–55.
5. Lovly CM, Dahlman KB, Fohn LE, Su Z, Dias-Santagata D, Hicks DJ, et al. Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. PLoS One. 2012;7(4):e35309.